Literature DB >> 22388641

Beta cell function: the role of macrophage migration inhibitory factor.

Ivana Stojanovic1, Tamara Saksida, Stanislava Stosic-Grujicic.   

Abstract

During evolution, beta cells adapted to a sole aim: the production and stimulus-dependent secretion of insulin. This acquired specificity was accompanied by a loss of protection mechanisms predisposing beta cell to a high vulnerability. Among beta cell-damaging molecules, a new one has been identified recently: macrophage migration inhibitory factor (MIF). MIF was at first designated as a T-cell product that inhibits random movement of macrophages. Over the years, the number of functions attributed to this protein increased significantly, positioning MIF at the top of inflammatory cascade in the combat against infection and in immunoinflammatory and autoimmune diseases. This exceptionally versatile molecule regulates insulin secretion in physiological conditions, while in pathological states it alters beta cell function and induces their apoptosis or necrosis and affects beta cell neoplasia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22388641     DOI: 10.1007/s12026-012-8281-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  56 in total

Review 1.  beta-Cell death during progression to diabetes.

Authors:  D Mathis; L Vence; C Benoist
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction.

Authors:  John A Taylor; Qing Zhu; Brian Irwin; Yazeed Maghaydah; John Tsimikas; Carol Pilbeam; Lin Leng; Richard Bucala; George A Kuchel
Journal:  Am J Physiol Renal Physiol       Date:  2006-07-11

3.  Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.

Authors:  Ivana Cvetkovic; Yousef Al-Abed; Djordje Miljkovic; Danijela Maksimovic-Ivanic; Jesse Roth; Michael Bacher; Hui Y Lan; Ferdinando Nicoletti; Stanislava Stosic-Grujicic
Journal:  Endocrinology       Date:  2005-03-24       Impact factor: 4.736

4.  Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha.

Authors:  J M Daun; J G Cannon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-09       Impact factor: 3.619

5.  Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.

Authors:  H Lue; M Thiele; J Franz; E Dahl; S Speckgens; L Leng; G Fingerle-Rowson; R Bucala; B Lüscher; J Bernhagen
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

6.  Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization.

Authors:  Frederic Chagnon; Christine N Metz; Richard Bucala; Olivier Lesur
Journal:  Circ Res       Date:  2005-05-05       Impact factor: 17.367

7.  Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway.

Authors:  Ralf Baumann; Carmen Casaulta; Dagmar Simon; Sébastien Conus; Shida Yousefi; Hans-Uwe Simon
Journal:  FASEB J       Date:  2003-12       Impact factor: 5.191

8.  Macrophage migration inhibitory factor and development of type-1 diabetes in non-obese diabetic mice.

Authors:  Jörg Bojunga; Klaus Kusterer; Michael Bacher; Ralf Kurek; Klaus-Henning Usadel; Heiner Renneberg
Journal:  Cytokine       Date:  2003-02-21       Impact factor: 3.861

9.  Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.

Authors:  Stanislava Stosic-Grujicic; Ivana Stojanovic; Danijela Maksimovic-Ivanic; Miljana Momcilovic; Dusan Popadic; Ljubica Harhaji; Djordje Miljkovic; Christine Metz; Katia Mangano; Gianpaolo Papaccio; Yousef Al-Abed; Ferdinando Nicoletti
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

10.  The role of macrophage migration inhibitory factor in mouse islet transplantation.

Authors:  Christian Toso; Véronique Serre-Beinier; Juliet Emamaullee; Shaheed Merani; Mathieu Armanet; Anne Wojtusciszyn; Domenico Bosco; Thierry Calandra; Thierry Roger; Philippe Morel; A M James Shapiro; Thierry Berney
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

View more
  8 in total

1.  Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic β Cell Dysfunction.

Authors:  Taiyi Kuo; Ja Young Kim-Muller; Timothy E McGraw; Domenico Accili
Journal:  J Biol Chem       Date:  2016-02-25       Impact factor: 5.157

2.  MIF deficiency does not alter glucose homeostasis or adipose tissue inflammatory cell infiltrates during diet-induced obesity.

Authors:  Sarah J Conine; Janet V Cross
Journal:  Obesity (Silver Spring)       Date:  2013-09-17       Impact factor: 5.002

3.  Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell.

Authors:  Langping Tan; Xiao Ye; Yu Zhou; Min Yu; Zhiqiang Fu; Ruiwan Chen; Baoxiong Zhuang; Bing Zeng; Huilin Ye; Wenchao Gao; Qing Lin; Zhihua Li; Quanbo Zhou; Rufu Chen
Journal:  J Transl Med       Date:  2014-04-07       Impact factor: 5.531

Review 4.  Nematode Orthologs of Macrophage Migration Inhibitory Factor (MIF) as Modulators of the Host Immune Response and Potential Therapeutic Targets.

Authors:  Justyna Karabowicz; Ewa Długosz; Piotr Bąska; Marcin Wiśniewski
Journal:  Pathogens       Date:  2022-02-17

5.  Nicotinamide-functionalized multiwalled carbon nanotubes increase insulin production in pancreatic beta cells via MIF pathway.

Authors:  Ioana Ilie; Razvan Ilie; Teodora Mocan; Flaviu Tabaran; Cornel Iancu; Lucian Mocan
Journal:  Int J Nanomedicine       Date:  2013-08-30

6.  Camel milk peptide improves wound healing in diabetic rats by orchestrating the redox status and immune response.

Authors:  Hossam Ebaid; Bahaa Abdel-Salam; Iftekhar Hassan; Jameel Al-Tamimi; Ali Metwalli; Ibrahim Alhazza
Journal:  Lipids Health Dis       Date:  2015-10-24       Impact factor: 3.876

Review 7.  The role of MIF in type 1 and type 2 diabetes mellitus.

Authors:  Yuriko I Sánchez-Zamora; Miriam Rodriguez-Sosa
Journal:  J Diabetes Res       Date:  2014-01-02       Impact factor: 4.011

8.  The cardioprotective effect of hypertonic saline is associated with inhibitory effect on macrophage migration inhibitory factor in sepsis.

Authors:  Yi-Li Wang; Kwok-Keung Lam; Pao-Yun Cheng; Ching-Wen Kung; Shu-Ying Chen; Chun-Chih Chao; Hwong-Ru Hwang; Ming-Ting Chung; Yen-Mei Lee
Journal:  Biomed Res Int       Date:  2013-11-26       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.